There is potential for new sealant, hemostasis and closure treatments designed to facilitate surgical treatments of neurological disorders; most existing alternative treatments are pharmological therapies limited to reducing symptoms and few cures exist. An important driver in this market segment is the increasing aging population, with a consequent growing prevalence of age-related disorders. Also, new [...]
Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial. Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective [...]
¶
Posted 18 February 2009
† P. Driscoll
§
ablation § biomaterials § biotech § cancer § cardiology § diabetes § diagnostics § drug § gastroenterology § innovation § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § pharmaceutical § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: ablation, anti-adhesion, cancer, cardiology, cyanoacrylate, diabetes, disc replacement, drug, fibrin glue, fibrin sealant, gastroenterology, hemostasis, innovation, market data, medical adhesive, medtech, microwave ablation, nanotech, obesity, ophthalmology, orthopedic, radiofrequency ablation, spine surgery, startups, surgical glue, surgical sealant, suture, thermal ablation, tissue engineering, ultrasound, urogenital, wound closure, wound management
More medtech trends Nanotechnology advances. The use of nanotechnology in medicine has faced as many overblown promises as any other application of nanotechnology. However, any realistic view of future medical technologies with big impact would be amiss if it did not consider the myriad applications of "nanotechnology", which we place in quotes to denote that [...]
Below is the coverage in the April 2008 issue of MedMarkets. Ablation: An Energized Market Demand for Hip and Knee Implants Expected to Increase MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, [...]
¶
Posted 13 May 2008
† P. Driscoll
§
biotech § cancer § cardiology § drug § innovation § market data § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: biotech, cancer, cardiology, drug, innovation, market data, medtech, nanotech, obesity, ophthalmology, orthopedic, spine, startups, surgery, tissue engineering, urogenital, wound management
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing. As all white papers should be, it’s free. Here’s the link so you can download it. bookmark to
¶
Posted 09 April 2008
† P. Driscoll
§
biotech § cancer § cardiology § drug § gastroenterology § innovation § market data § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: biotech, cancer, cardiology, drug, gastroenterology, innovation, market data, medtech, nanotech, obesity, ophthalmology, orthopedic, spine, startups, surgery, tissue engineering, urogenital, wound management
(From the September 2007 issue of MedMarkets) Drawing upon the clinical and technology sectors we have addressed in MedMarkets and the Market and Technology Reports of MedMarket Diligence, we have previously identified a number of areas where we see substantial growth in medical technology markets. In our white paper, High Growth Medical Technologies, we note [...]
¶
Posted 26 September 2007
† P. Driscoll
§
biotech § cancer § cardiology § gastroenterology § market data § medtech § nanotech § neurology § obesity § orthopedic § surgery § tissue engineering
‡
°
Also tagged: biotech, cancer, cardiology, gastroenterology, market data, medtech, nanotech, obesity, orthopedic, surgery, tissue engineering
Surgical wounds are projected to increase in number at an annual rate of 3%, but overall the severity and size of surgical wounds will continue to decrease over the next five years as a result of the continuing trend toward minimally invasive surgery. Surgical procedures generate a large number of uncomplicated acute wounds with uneventful [...]
Not every start-up succeeds. But every single successful medical technology company was once a start-up. From a primary consideration, start-up companies have been founded based on: (1) what technologies they consider possible, and (2) the need for clinical solutions to problems that exist in health care. For this reason, we look at the range of [...]
The terms “sealant” and “glue” tend to be used interchangeably in the surgical context, but in fact there is a difference in adhesive strength between sealants, pioneered by fibrin products (sometimes homemade) and the later, stronger glues of which cyanoacrylate-based products were the leaders. Fibrin sealants represented a revolution in local hemostatic measures for both [...]
I have to admit that at times I feel like a broken record, repeatedly pointing out the fact that medical technologies — medical devices in particular — are frequently found to be providing clinical solutions to problems that neither drug companies nor biotech companies are able to achieve. It’s a sort of yankee ingenuity made [...]